StockData

CapsoVision vs Vivani Medical

CV and VANI side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CV and VANI compare

CapsoVision is the larger company, worth 3.3 times as much as Vivani Medical ($302M against $91.1M).

CapsoVision scores higher on the StockData Score (6 against 5 for Vivani Medical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCVVANI
Size and price
Market cap$302M$91.1M
Share price$6.03$1.01
Change, 1 year8.8%−34.0%
Change, 5 years–−85.6%
Beta (5Y)−1.151.12
Employees9936
StockData Score
Total score6 (better)5
Valuation score00
Growth score00
Performance score00
Health score6 (better)5
Dividend score00
Valuation
P/S21.7×–
P/B11.4×6.9× (better)
FCF yield−9.7% (better)−28.2%
Fair value$1.25–
Margin of safety−383%–
Growth
Revenue growth (TTM)6.4%–
Profitability
Gross margin49.7%–
Operating margin−212%–
Net margin−210%–
FCF margin−210%–
Return on equity−125% (better)−372%
Return on invested capital−99.6%–
Financial health
Debt / equity0.000.00
Current ratio5.07 (better)2.40
Altman Z-score19.14 (better)−6.53
Piotroski F-score3 (better)2
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions10.2%5.8%
Held by insiders29.0%53.5%
Insider net buying, 12 months$21.0M (better)$16.7M
Short interest, % of float5.5%0.88%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.